Axonics Inc (NASDAQ: AXNX) – Suitable For Long Term Buy?
BlackRock Fund Advisors recently announced the acquisition of new stake in Axonics Inc (NASDAQ:AXNX). The institutional investor has increased its shareholding in the Healthcare company by 3.44% to 3.38 million shares with purchase of 0.11 million shares. This fresh investment now brings its stake to 6.67% valued currently at $189.23 million. In addition, Fidelity Management […]
